L-ficolin binds to the glycoproteins hemagglutinin and neuraminidase and inhibits influenza a virus infection both in vitro and in vivo

Journal of Innate Immunity

Volumn 4, Issue 3, 2012, Pages 312-324

  Pan, Qin ^a   Chen, Haidan ^a   Wang, Feng ^a   Jeza, Victor Tunje ^a   Hou, Wei ^b   Zhao, Yinglan ^a   Xiang, Tian ^a   Zhu, Ying ^c   Endo, Yuchi ^d   Fujita, Teizo ^d   Zhang, Xiao Lian ^a,b  

^a School of Pharmaceutical Sciences   (China)

^b WUHAN UNIVERSITY   (China)

^c WUHAN UNIVERSITY   (China)

^d FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Complement; Glycoprotein; Hemagglutinin; Influenza infection; L ficolin; Neuraminidase

Indexed keywords

FICOLIN; GLYCOPROTEIN; HEMAGGLUTININ; N ACETYLGLUCOSAMINE; SIALIDASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; IN VITRO STUDY; IN VIVO STUDY; INFECTION SENSITIVITY; INFLUENZA A; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN BINDING; VIRUS ENTRY;

ACETYLGLUCOSAMINE; ANIMALS; CELL LINE; COMPLEMENT PATHWAY, MANNOSE-BINDING LECTIN; DISEASE MODELS, ANIMAL; HEMAGGLUTININS; HUMANS; INFLUENZA A VIRUS; LECTINS; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; NEURAMINIDASE; ORTHOMYXOVIRIDAE INFECTIONS; PROTEIN BINDING; TRANSGENES; VIRUS INTERNALIZATION;

EID: 84862796428     PISSN: 1662811X     EISSN: 16628128     Source Type: Journal    
DOI: 10.1159/000335670     Document Type: Article

References (42)

1. Fujita T: Evolution of the lectin-complement pathway and its role in innate immunity. Nat Rev Immunol 2002; 2: 346-353. (Pubitemid 37328757)
2. Fujita T, Matsushita M, Endo Y: The lectincomplement pathway -its role in innate immunity and evolution. Immunol Rev 2004; 198: 185-202. (Pubitemid 38406944)
3. Matsushita M, Endo Y, Taira S, Sato Y, Fujita T, et al: A novel human serum lectin with collagen-and fibrinogen-like domains that functions as an opsonin. J Biol Chem 1996; 271: 2448-2454. (Pubitemid 26047848)
4. Sugimoto R, Yae Y, Akaiwa M, Kitajima S, Shibata Y, et al: Cloning and characterization of the Hakata antigen, a member of the ficolin/opsonin p35 lectin family. J Biol Chem 1998; 273: 20721-20727. (Pubitemid 28385347)
5. Endo Y, Sato Y, Matsushita M, Fujita T: Cloning and characterization of the human lectin P35 gene and its related gene. Genomics 1996; 36: 515-521. (Pubitemid 26321974)
6. Lynch NJ, Roscher S, Hartung T, Morath S, Matsushita M, et al: L-ficolin specifically binds to lipoteichoic acid, a cell wall constituent of Gram-positive bacteria, and activates the lectin pathway of complement. J Immunol 2004; 172: 1198-1202. (Pubitemid 38113782)
7. Nahid AM, Sugii S: Binding of porcine ficolin-alpha to lipopolysaccharides from Gramnegative bacteria and lipoteichoic acids from Gram-positive bacteria. Dev Comp Immunol 2006; 30: 335-343. (Pubitemid 41571273)
8. Zhang XL, Ali MA: Ficolins: Structure, function and associated diseases. Adv Exp Med Biol 2008; 632: 105-115.
9. Runza VL, Schwaeble W, Mannel DN: Ficolins: Novel pattern recognition molecules of the innate immune response. Immunobiology 2008; 213: 297-306. (Pubitemid 351479859)
10. Kwon S, Kim MS, Kim D, Lee KW, Choi SY, et al: Identification of a functionally relevant signal peptide of mouse ficolin A. J Biochem Mol Biol 2007; 40: 532-538. (Pubitemid 47281473)
11. Neumann G, Noda T, Kawaoka Y: Emergence and pandemic potential of swine-origin H1N1 influenza virus. Nature 2009; 459: 931-939.
12. Wikramaratna PS, Gupta S: Influenza outbreaks. Cell Microbiol 2009; 11: 1016-1024.
13. Smith JH, Nagy T, Barber J, Brooks P, Tompkins SM, et al: Aerosol inoculation with a sub-lethal influenza virus leads to exacerbated morbidity and pulmonary disease pathogenesis. Viral Immunol 2011; 24: 131-142.
14. Ghedin E, Sengamalay NA, Shumway M, Zaborsky J, Feldblyum T, et al: Large-scale sequencing of human influenza reveals the dynamic nature of viral genome evolution. Nature 2005; 437: 1162-1166. (Pubitemid 41509354)
15. McHardy AC, Adams B: The role of genomics in tracking the evolution of influenza A virus. PLoS Pathog 2009; 5:e1000566.
16. Taira S, Kodama N, Matsushita M, Fujita T: Opsonic function and concentration of human serum ficolin/P35. Fukushima J Med Sci 2000; 46: 13-23.
17. Matsushita M, Fujita T: Ficolins and the lectin complement pathway. Immunol Rev 2001; 180: 78-85. (Pubitemid 32472854)
18. Asahi Y, Yoshikawa T, Watanabe I, Iwasaki T, Hasegawa H, et al: Protection against influenza virus infection in polymeric Ig receptor knockout mice immunized intranasally with adjuvant-combined vaccines. J Immunol 2002; 168: 2930-2938. (Pubitemid 34211673)
19. Scull MA, Gillim-Ross L, Santos C, Roberts KL, Bordonali E, et al: Avian influenza virus glycoproteins restrict virus replication and spread through human airway epithelium at temperatures of the proximal airways. PLoS Pathog 2009; 5:e1000424.
20. Zhang W, Wang CY, Yang ST, Qin C, Hu JL, et al: Inhibition of highly pathogenic avian influenza virus H5N1 replication by the small interfering RNA targeting polymerase A gene. Biochem Biophys Res Commun 2009; 390: 421-426.
21. Krarup A, Sorensen UB, Matsushita M, Jensenius JC, Thiel S: Effect of capsulation of opportunistic pathogenic bacteria on binding of the pattern recognition molecules mannan-binding lectin, L-ficolin, and H-ficolin. Infect Immun 2005; 73: 1052-1060. (Pubitemid 40165766)
22. Liu J, Ali MA, Shi Y, Zhao Y, Luo F, et al: Specifically binding of L-ficolin to N-glycans of HCV envelope glycoproteins E1 and E2 leads to complement activation. Cell Mol Immunol 2009; 6: 235-244.
23. Fujimori Y, Harumiya S, Fukumoto Y, Miura Y, Yagasaki K, et al: Molecular cloning and characterization of mouse ficolin-A. Biochem Biophys Res Commun 1998; 244; 796-800. (Pubitemid 28418148)
24. Ma Y, Chen H, Wang Q, Luo F, Yan J: IL-24 protects against Salmonella typhimurium infection by stimulating early neutrophil Th1 cytokine production, which in turn activates CD8+ T cells. Eur J Immunol 2009; 39: 3357-3368.
25. Chen Z, Matsuo K, Asanuma H, Takahashi H, Iwasaki T, et al: Enhanced protection against a lethal influenza virus challenge by immunization with both hemagglutinin and neuraminidase-expressing DNAs. Vaccine 1999; 17: 653-659. (Pubitemid 29074718)
26. Wang QL, Pan Q, Ma Y, Wang K, Sun P, et al: An attenuated Salmonella-vectored vaccine elicits protective immunity against Mycobacterium tuberculosis. Vaccine 2009; 27: 6712-6722.
27. Sukumar N, Sloan GP, Conover MS, Love CF, Mattoo S, et al: Cross-species protection mediated by a Bordetella bronchiseptica strain lacking antigenic homologs present in acellular pertussis vaccines. Infect Immun 2010; 78: 2008-2016.
28. Lee GC, Jeon ES, Kim WS, Le DT, Yoo JH, et al: Evaluation of a rapid diagnostic test, NanoSign Influenza A/B Antigen, for detection of the 2009 pandemic influenza A/ H1N1 viruses. Virol J 2010; 7: 244.
29. McSharry JJ, Weng Q, Brown A, Kulawy R, Drusano GL: Prediction of the pharmacodynamically linked variable of oseltamivir carboxylate for influenza A virus using an in vitro hollow-fiber infection model system. Antimicrob Agents Chemother 2009; 53: 2375-2381.
30. Drakulovski P, Carcy B, Moubri K, Carret C, Depoix D, et al: Antibodies raised against Bcvir15, an extrachromosomal doublestranded RNA-encoded protein from Babesia canis, inhibit the in vitro growth of the parasite. Infect Immun 2003; 71: 1056-1067. (Pubitemid 36254284)
31. Gravelat FN, Doedt T, Chiang LY, Liu H, Filler SG, et al: In vivo analysis of Aspergillus fumigatus developmental gene expression determined by real-time reverse transcription-PCR. Infect Immun 2008; 76: 3632-3639.
32. Verfaillie T, Cox E, Goddeeris BM: Immunostimulatory capacity of DNA vaccine vectors in porcine PBMC: A specific role for CpGmotifs? Vet Immunol Immunopathol 2005; 103: 141-151. (Pubitemid 40038229)
33. Lu J, Teh C, Kishore U, Reid KB: Collectins and ficolins: Sugar pattern recognition molecules of the mammalian innate immune system. Biochim Biophys Acta 2002; 1572: 387-400. (Pubitemid 35246356)
34. Skehel JJ, Wiley DC: Receptor binding and membrane fusion in virus entry: The influenza hemagglutinin. Annu Rev Biochem 2000; 69: 531-569.
35. Wagner R, Matrosovich M, Klenk HD: Functional balance between haemagglutinin and neuraminidase in influenza virus infections. Rev Med Virol 2002; 12: 159-166. (Pubitemid 34516947)
36. Reading PC, Tate MD, Pickett DL, Brooks AG: Glycosylation as a target for recognition of influenza viruses by the innate immune system. Adv Exp Med Biol 2007; 598: 279-292.
37. Leikina E, Delanoe-Ayari H, Melikov K, Cho MS, Chen A, et al: Carbohydrate-binding molecules inhibit viral fusion and entry by crosslinking membrane glycoproteins. Nat Immunol 2005; 6: 995-1001. (Pubitemid 41486184)
38. Chang WC, Hartshorn KL, White MR, Moyo P, Michelow IC, et al: Recombinant chimeric lectins consisting of mannosebinding lectin and L-ficolin are potent inhibitors of influenza A virus compared with mannose-binding lectin. Biochem Pharmacol 2011; 81: 388-395.
39. Job ER, Deng YM, Tate MD, Bottazzi B, Crouch EC, et al: Pandemic H1N1 influenza A viruses are resistant to the antiviral activities of innate immune proteins of the collectin and pentraxin superfamilies. J Immunol 2010; 185: 4284-4291.
40. Hartshorn KL, White MR, Voelker DR, Coburn J, Zaner K, et al: Mechanism of binding of surfactant protein D to influenza A viruses: Importance of binding to haemagglutinin to antiviral activity. Biochem J 2000; 351: 449-458.
41. van Eijk M, White MR, Batenburg JJ, Vaandrager AB, van Golde LM, et al: Interactions of influenza A virus with sialic acids present on porcine surfactant protein D. Am J Respir Cell Mol Biol 2004; 30: 871-879. (Pubitemid 38736912)
42. Cedzynski M, Nuytinck L, Atkinson AP, St Swierzko A, Zeman K, et al: Extremes of Lficolin concentration in children with recurrent infections are associated with single nucleotide polymorphisms in the FCN2 gene. Clin Exp Immunol 2007; 150: 99-104. (Pubitemid 47383302)